0001386301 false 0001386301 2023-09-13 2023-09-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report:

(Date of earliest event reported)

 

September 13, 2023

 

 

 

Research Solutions, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

(State or other Jurisdiction of Incorporation)

 

1-39256

  11-3797644
(Commission File Number)   (IRS Employer Identification No.)

 

N/A

(Address of Principal Executive Offices and zip code)

 

(310) 477-0354

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class Trading Symbol(s) Name of each Exchange on which  registered
Common stock, $0.001 par value RSSS

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company     ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

 

 

 

 

 

 

Item 2.02.Results of Operations and Financial Condition.

 

On September 13, 2023, the Registrant announced its financial results for the fourth quarter and fiscal year ended June 30, 2023. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth by specific reference in such filing.

 

Item 9.01.Financial Statements and Exhibits

 

(d)Exhibits.

 

  Exhibit
Number
Description
99.1 Press Release issued September 13, 2023 entitled “Research Solutions Announces Fiscal Fourth Quarter and Full Year 2023 Results”.
104Cover Page Interactive Data File (embedded as Inline XBRL document)

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  RESEARCH SOLUTIONS, INC.
   
   
Date: September 13, 2023 By: /s/ William Nurthen
    William Nurthen
    Chief Financial Officer

 

 

 

Exhibit 99.1

 

FOR IMMEDIATE RELEASE

 

 

Research Solutions Announces Fiscal Fourth Quarter and Full Year 2023 Results

 

Reports Full-Year GAAP Net Income, Record Adjusted EBITDA and 28% Increase in Platform Revenue

 

HENDERSON, Nev., September 13, 2023 — Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, reported financial results for its fiscal fourth quarter and full year ended June 30, 2023.

 

Fiscal Fourth Quarter 2023 Summary

 

Total revenue increased 16% to $10.0 million
Platform revenue up 22% to $2.3 million; Annual recurring revenue up 19% to $9.4 million
Gross profit up 19% to the prior-year quarter; Total gross margin improved 110 basis points to 39.4%
Net income of $375,746 or one cent per diluted share, compared to a net loss of ($438,267) or one cent per share in the prior-year quarter
Adjusted EBITDA of $825,087 compared to ($121,327) in the same period a year ago
Cash flow from operations of $1.5 million compared to slightly negative cash flow in the prior-year quarter

 

Full-Year Fiscal 2023 Summary

 

Total revenue increased 14% to $37.7 million
Platform revenue of $8.7 million, a 28% increase, with a 14% increase in total deployments to 835
Total gross margin increased 250 basis points to 39.0%
Net income of $0.6 million, or $0.02 per diluted share, compared to a net loss of $1.6 million or ($0.06) per share in the prior year
Adjusted EBITDA of $2.0 million compared to ($0.4 million) in the previous year
Cash flow from operations of $3.4 million, compared to ($0.4 million) in the previous year

 

 

 

 

Items Subsequent to End of Fiscal 2023

 

Acquired ResoluteAI, a developer of advanced search and discovery tools
Engaged Jeremy Murphy as an advisor and observer to the Board of Directors

 

“Fiscal year 2023 was an exciting year for our business. Our results represent the significant progress made across our organization, highlighted by our highest annual organic revenue growth in more than a decade and first year of GAAP profitability since fiscal 2015,” said Roy W. Olivier, President and CEO of Research Solutions. “Our customers continue to recognize the greater efficiency and cost savings offered through our Article Galaxy platform and our recent acquisition of ResoluteAI expands these offerings and capabilities, providing us with meaningful cross-selling opportunities. While we continue to see headwinds in the platform business, we are optimistic about our fiscal year 2024 and look to continue to grow the business organically as well as through strategic M&A.”

 

Fiscal Fourth Quarter 2023 Results

 

Total revenue increased 16% to $10.0 million, compared to $8.6 million in the same year-ago quarter.

 

Platform subscription revenue increased 22% to $2.3 million compared to approximately $1.9 million in the year-ago quarter. The increase was primarily due to an increase in upsell activity within our existing customer base and an increase in the total number of paid Platform deployments, including 20 added in the quarter. The quarter ended with annual recurring revenue of $9.4 million, up 4% sequentially and 19% year-over-year (see the company's definition of annual recurring revenue below).

 

Transaction revenue was up 15%, increasing to $7.7 million, compared to $6.7 million in the fourth quarter of fiscal 2022. Transaction customers count for the quarter was 1,404, compared to 1,213 customers in the prior year quarter (see the company's definition of active customer accounts and transactions below).

 

Total gross margin improved 110 basis points from the prior-year quarter to 39.4%. The increase was primarily driven by a continued revenue mix shift to the higher-margin Platform business.

 

Total operating expenses were approximately $3.7 million, a $62,000 decrease from the fourth quarter of 2022. The decrease was primarily due to lower sales and marketing expenses.

 

Net income in the fourth quarter was $376,000, or one cent per diluted share, compared to a net loss of ($438,000), or two cents per share, in the prior-year quarter. Adjusted EBITDA was $825,000, compared to ($121,000) in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

 

Full-Year Fiscal 2023 Results

 

Total revenue increased 14% to $37.7 million, compared to $32.9 million in fiscal 2022.

 

Platform subscription revenue was $8.7 million, a 28% increase over the prior year. The increase was due to upselling current platform customers and an increase in the total number of paid Platform deployments.

 

 

 

 

Transaction revenue was $29.0 million, an 11% increase compared to the previous year. The increase is primarily due to organic growth and also the acquisition of certain customer contracts from FIZ Karlsruhe which became effective in the third quarter of fiscal 2023.

 

Total gross margin improved 250 basis points over the prior year to 39.0%. The increase was primarily driven by a continued revenue mix shift to the higher-margin Platform business.

 

Total operating expenses were $14.5 million compared to $13.7 million in the prior year. The increase was primarily due to higher stock compensation expense related to the transition to a new program that the Company views as better aligned with shareholders’ interests.

 

Net income for fiscal year 2023 was $572,000, or $0.02 per diluted share. Net loss in fiscal 2022 was $1.6 million, or ($0.06) per share. Adjusted EBITDA for fiscal 2023 was a positive $2.0 million, compared to a negative $374,000 in the prior year (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

 

Cash and cash equivalents on June 30, 2023, amounted to $13.5 million compared to $10.6 million as of June 30, 2022. There were no outstanding borrowings under the company's $2.5 million revolving line of credit and the company had no long-term liabilities or other debt.

 

 

Conference Call

 

Research Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer period.

 

Date: Wednesday, September 13, 2023

Time: 5:00 p.m. ET (2:00 p.m. PT)

Dial-in number: 1-412-317-5180

Conference ID: 10182138

 

The conference call will be broadcast live and available for replay until October 13, 2023, by dialing 1-412-317-6671 and using the replay ID 10182138, and via the investor relations section of the company's website at http://researchsolutions.investorroom.com/.

 

 

 

 

Fiscal Fourth Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter

 

   Quarter Ended June 30,     
   2023   2022   Change   % Change 
Revenue:                
Platforms  $2,303,375   $1,886,845   $416,530    22.1%
Transactions  $7,656,342   $6,675,164    981,178    14.7%
Total Revenue   9,959,717    8,562,009    1,397,708    16.3%
                     
Gross Profit:                    
Platforms   2,028,265    1,646,631    381,634    23.2%
Transactions   1,892,278    1,636,511    255,767    15.6%
Total Gross Profit   3,920,543    3,283,142    637,401    19.4%
                     
Gross profit as a % of revenue:                    
Platforms   88.1%   87.3%   0.8%     
Transactions   24.7%   24.5%   0.2%     
Total Gross Profit   39.4%   38.3%   1.0%     
                     
Operating Expenses:                    
Sales and marketing   455,030    691,368    (236,338)   -34.2%
Technology and product development   991,093    1,049,430    (58,337)   -5.6%
General and administrative   1,649,333    1,663,671    (14,339)   -0.9%
Depreciation and amortization   22,163    5,507    16,656    302.5%
Stock-based compensation   585,384    225,501    359,883    159.6%
Foreign currency translation loss   (37,743)   91,279    (129,022)   NM 
Total Operating Expenses   3,665,260    3,726,756    (61,497)   -1.7%
Income (loss) from operations   255,283    (443,614)   698,897    157.5%
                     
Other Income (Expenses):                    
Other income (expense)   120,522    6,377    114,145    NM 
Provision for income taxes   (59)   (1,030)   971    -94.3%
Total Other Income (Expenses):   120,463    5,347    115,116    NM 
Net income (loss)  $375,746   $(438,267)   814,013    185.7%
Adjusted EBITDA  $825,087   $(121,327)  $946,414    NM 

 

   Quarter Ended June 30,     
   2023   2022   Change   % Change 
Platforms:                
ARR (Annual recurring revenue):                    
Beginning of Period  $9,107,681   $7,348,847   $1,758,834    23.9%
Incremental ARR   336,449    573,341    (236,892)   -41.3%
End of Period  $9,444,130   $7,922,188   $1,521,942    19.2%
                     
Deployments:                    
Beginning of Period   815    680    135    19.9%
Incremental Deployments   20    53    (33)   -62.3%
End of Period   835    733    102    13.9%
                     
ASP (Average sales price):                    
Beginning of Period  $11,175   $10,807   $368    3.4%
End of Period  $11,310   $10,808   $502    4.6%
                     
Transaction Customers:                    
Corporate customers   1,090    920    170    18.5%
Academic customers   314    293    21    7.2%
Total customers   1,404    1,213    191    15.7%

 

 

 

 

Fiscal Full Year Financial and Operational Summary Tables vs. Prior-Year

 

   Twelve Months Ended June 30,     
   2023   2022   Change   % Change 
Revenue:                
Platforms  $8,683,246   $6,787,772   $1,895,474    27.9%
Transactions  $29,020,206   $26,146,380    2,873,826    11.0%
Total Revenue   37,703,452    32,934,152    4,769,300    14.5%
                     
Gross Profit:                    
Platforms   7,655,960    5,851,183    1,804,777    30.8%
Transactions   7,044,931    6,168,491    876,440    14.2%
Total Gross Profit   14,700,891    12,019,674    2,681,217    22.3%
                     
Gross profit as a % of revenue:                    
Platforms   88.2%   86.2%   2.0%     
Transactions   24.3%   23.6%   0.7%     
Total Gross Profit   39.0%   36.5%   2.5%     
                     
Operating Expenses:                    
Sales and marketing   2,285,478    2,276,172    9,306    0.4%
Technology and product development   3,742,192    3,711,085    31,107    0.8%
General and administrative   6,654,012    6,406,400    247,612    3.9%
Depreciation and amortization   52,649    17,651    34,998    198.3%
Stock-based compensation   1,849,906    1,096,384    753,522    68.7%
Foreign currency translation loss   (121,953)   143,898    (265,851)   NM 
Total Operating Expenses   14,462,284    13,651,590    810,694    5.9%
Income (loss) from operations   238,608    (1,631,916)   1,870,523    114.6%
                     
Other Income (Expenses):                    
Other income (expense)   338,617    7,154    331,463    NM 
Provision for income taxes   (5,602)   (7,622)   2,020    -26.5%
Total Other Income (Expenses):   333,015    (468)   333,483    NM 
Net income (loss)  $571,623   $(1,632,384)   2,204,006    135.0%
Adjusted EBITDA  $2,019,210   $(373,983)  $2,393,192    NM 

 

   Twelve Months Ended June 30,     
   2023   2022   Change   % Change 
Platforms:                
ARR (Annual recurring revenue):                    
Beginning of Period  $7,922,188   $5,880,179   $2,042,009    34.7%
Incremental ARR   1,521,942    2,042,009    (520,067)   -25.5%
End of Period  $9,444,130   $7,922,188   $1,521,942    19.2%
                     
Deployments:                    
Beginning of Period   733    553    180    32.5%
Incremental Deployments   102    180    (78)   -43.3%
End of Period   835    733    102    13.9%
                     
ASP (Average sales price):                    
Beginning of Period  $10,808   $10,633   $175    1.6%
End of Period  $11,310   $10,808   $502    4.6%
                     
Transaction Customers:                    
Corporate customers   1,012    886    126    14.2%
Academic customers   304    299    5    1.6%
Total customers   1,316    1,185    131    11.1%

 

 

 

 

Active Customer Accounts, Transactions and Annual Recurring Revenue

 

The company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

 

A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

 

The company defines annual recurring revenue as the value of contracted Platform subscription recurring revenue normalized to a one-year period.

 

Use of Non-GAAP Measure – Adjusted EBITDA

 

Research Solutions’ management evaluates and makes operating decisions using various financial metrics. In addition to the company’s GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the company’s operating results.

 

The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other income (expense), foreign currency transaction loss, provision for income taxes, depreciation and amortization, stock-based compensation, gain on sale of discontinued operations, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):

 

   Quarter Ended June 30,     
   2023   2022   Change   % Change 
Net Income (loss)  $375,746   $(438,267)  $814,013    185.7%
Add (deduct):                    
Other income (expense)   (120,522)   (6,377)   (114,145)   NM 
Foreign currency translation loss   (37,743)   91,279    (129,022)   -141.3%
Provision for income taxes   59    1,030    (971)   -94.3%
Depreciation and amortization   22,163    5,507    16,656    302.5%
Stock-based compensation   585,384    225,501    359,883    159.6%
Adjusted EBITDA  $825,087   $(121,327)  $946,414    NM 

 

   Twelve Months Ended June 30,     
   2023   2022   Change   % Change 
Net Income (loss)  $571,623   $(1,632,384)  $2,204,006    135.0%
Add (deduct):             -      
Other income (expense)   (338,617)   (7,154)   (331,463)   NM 
Foreign currency translation loss   (121,953)   143,898    (265,851)   -184.7%
Provision for income taxes   5,602    7,622    (2,020)   -26.5%
Depreciation and amortization   52,649    17,651    34,998    198.3%
Stock-based compensation   1,849,906    1,096,384    753,522    68.7%
Adjusted EBITDA  $2,019,210   $(373,983)  $2,393,192    NM 

 

 

 

 

About Research Solutions

 

Research Solutions, Inc. (NASDAQ: RSSS) provides cloud-based technologies to streamline the process of obtaining, managing, and creating intellectual property. Founded in 2006 as Reprints Desk, the company was a pioneer in developing solutions to serve researchers. Today, more than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on Article Galaxy, the company's SaaS research platform, to streamline access to the latest scientific research and data with 24/7 customer support. For more information and details, please visitwww.researchsolutions.com and www.reprintsdesk.com

 

Important Cautions Regarding Forward-Looking Statements

 

Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding improved product offerings and cross-selling opportunities, , management’s optimistic outlook for fiscal 2024, and the Company’s prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission. 

 

 

 

 

Research Solutions, Inc. and Subsidiaries

Consolidated Balance Sheets

 

   June 30,   June 30, 
   2023   2022 
Assets          
Current assets:          
Cash and cash equivalents  $13,545,333   $10,603,175 
Accounts receivable, net of allowance of $85,015 and $94,144, respectively   6,153,063    5,251,545 
Prepaid expenses and other current assets   400,340    276,026 
Prepaid royalties   1,202,678    846,652 
Total current assets   21,301,414    16,977,398 
           
Other assets:          
Property and equipment, net of accumulated depreciation of $881,908 and $840,996, respectively   70,193    47,985 
Intangible assets, net of accumulated amortization of $747,355 and $723,036, respectively   462,068     
Deposits and other assets   1,052    893 
Total assets  $21,834,727   $17,026,276 
           
Liabilities and Stockholders’ Equity          
Current liabilities:          
Accounts payable and accrued expenses  $8,079,516   $6,604,032 
Deferred revenue   6,424,724    5,538,526 
Total current liabilities   14,504,240    12,142,558 
           
Commitments and contingencies          
           
Stockholders’ equity:          
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding        
Common stock; $0.001 par value; 100,000,000 shares authorized; 29,487,508 and 27,075,648 shares issued and outstanding, respectively   29,487    27,076 
Additional paid-in capital   29,941,873    28,072,855 
Accumulated deficit   (22,522,649)   (23,094,272)
Accumulated other comprehensive loss   (118,224)   (121,941)
Total stockholders’ equity   7,330,487    4,883,718 
Total liabilities and stockholders’ equity  $21,834,727   $17,026,276 

 

 

 

 

Research Solutions, Inc. and Subsidiaries

Consolidated Statements of Operations and Other Comprehensive Loss

 

   Years Ended 
   June 30, 
   2023   2022 
Revenue:          
Platforms  $8,683,246   $6,787,772 
Transactions   29,020,206    26,146,380 
Total revenue   37,703,452    32,934,152 
           
Cost of revenue:          
Platforms   1,027,286    936,589 
Transactions   21,975,275    19,977,889 
Total cost of revenue   23,002,561    20,914,478 
Gross profit   14,700,891    12,019,674 
           
Operating expenses:          
Selling, general and administrative   14,409,634    13,633,939 
Depreciation and amortization   52,649    17,651 
Total operating expenses   14,462,283    13,651,590 
           
Income (loss) from operations   238,608    (1,631,916)
           
Other income   338,617    7,154 
           
Income (loss) from operations before provision for income taxes   577,225    (1,624,762)
Provision for income taxes   (5,602)   (7,622)
           
Net income (loss)   571,623    (1,632,384)
           
Other comprehensive income (loss):          
Foreign currency translation   3,717    (2,364)
Comprehensive income (loss)  $575,340   $(1,634,748)
           
Basic income (loss) per common share:          
Net income (loss) per share  $0.02   $(0.06)
Weighted average common shares outstanding   26,860,761    26,422,295 
           
Diluted income (loss) per common share:          
Net income (loss) per share  $0.02   $(0.06)
Weighted average common shares outstanding   29,139,759    26,422,295 

 

 

 

 

Research Solutions, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

 

   Years Ended 
   June 30, 
   2023   2022 
Cash flow from operating activities:          
Net income (loss)  $571,623   $(1,632,384)
Adjustment to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Depreciation and amortization   52,649    17,651 
Fair value of vested stock options   375,189    470,615 
Fair value of vested restricted common stock   1,418,718    557,496 
Fair value of vested unrestricted common stock   68,272     
Modification cost of stock options   56,000     
Changes in operating assets and liabilities:          
Accounts receivable   (901,518)   (534,092)
Prepaid expenses and other current assets   (124,314)   (5,774)
Prepaid royalties   (356,026)   58,269 
Accounts payable and accrued expenses   1,337,056    (83,156)
Deferred revenue   886,198    734,175 
Net cash provided by (used in) operating activities   3,383,847    (417,200)
           
Cash flow from investing activities:          
Purchase of property and equipment   (47,209)   (44,288)
Payment for non-refundable deposit for asset acquisition   (297,450)    
Net cash used in investing activities   (344,659)   (44,288)
           
Cash flow from financing activities:          
Proceeds from the exercise of stock options   57,500    97,688 
Proceeds from the exercise of warrants       59,500 
Common stock repurchase   (104,250)   (93,918)
Payment of contingent acquisition consideration   (50,509)    
Net cash provided by (used in) financing activities   (97,259)   63,270 
           
Effect of exchange rate changes   229    (2,944)
Net increase (decrease) in cash and cash equivalents   2,942,158    (401,162)
Cash and cash equivalents, beginning of period   10,603,175    11,004,337 
Cash and cash equivalents, end of period  $13,545,333   $10,603,175 
           
Supplemental disclosures of cash flow information:          
Cash paid for income taxes  $5,602   $7,622 
           
Non-cash investing and financing activities:          
Contingent consideration accrual on asset acquisition  $138,428   $ 

 

 

Contact

Steven Hooser or John Beisler

Three Part Advisors

(214) 872-2710

 

shooser@threepa.com; jbeisler@threepa.com

 

# # #

 

 

 

v3.23.2
Cover
Sep. 13, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 13, 2023
Entity File Number 1-39256
Entity Registrant Name Research Solutions, Inc.
Entity Central Index Key 0001386301
Entity Tax Identification Number 11-3797644
Entity Incorporation, State or Country Code NV
City Area Code 310
Local Phone Number 477-0354
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, $0.001 par value
Trading Symbol RSSS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

Grafico Azioni Research Solutions (NASDAQ:RSSS)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Research Solutions
Grafico Azioni Research Solutions (NASDAQ:RSSS)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Research Solutions